Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?
Benyahia C, Gomez I, Kanyinda L, Boukais K, Danel C, Leséche G, Longrois D, Norel X.
Pulm Pharmacol Ther. 2012 Feb;25(1):115-8. Epub 2012 Jan 6.
Related citations
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience.
Tzortzaki EG, Georgiou A, Kampas D, Lemessios M, Markatos M, Adamidi T, Samara K, Skoula G, Damianaki A, Schiza S, Tzanakis N, Siafakas NM.
Pulm Pharmacol Ther. 2012 Feb;25(1):77-82. Epub 2011 Dec 3.
Effect of verapamil on bronchial goblet cells of asthma: an experimental study on sensitized animals.
Khakzad MR, Mirsadraee M, Mohammadpour A, Ghafarzadegan K, Hadi R, Saghari M, Meshkat M.
Pulm Pharmacol Ther. 2012 Apr;25(2):163-8. Epub 2011 Nov 25.
Models and approaches to understand the role of airway remodelling in disease.
McAnulty RJ.
Pulm Pharmacol Ther. 2011 Oct;24(5):478-86. Epub 2011 Jul 29. Review.
Current and future models for understanding airway diseases.
Burgess JK.
Pulm Pharmacol Ther. 2011 Oct;24(5):443. Epub 2011 Jul 27. No abstract available.
Small animals models for drug discovery.
Martin JG, Novali M.
Pulm Pharmacol Ther. 2011 Oct;24(5):513-24. Epub 2011 May 12. Review.
Models to understand contractile function in the airways.
Chitano P.
Pulm Pharmacol Ther. 2011 Oct;24(5):444-51. Epub 2011 Apr 14. Review.
Minimally invasive multiphoton and harmonic generation imaging of extracellular matrix structures in lung airway and related diseases.
Abraham T, Hirota JA, Wadsworth S, Knight DA.
Pulm Pharmacol Ther. 2011 Oct;24(5):487-96. Epub 2011 Apr 7. Review.
The dynamic face of respiratory research: understanding the effect of airway disease on a lung in constant motion.
Chapman DG, Brown NJ, Salome CM.
Pulm Pharmacol Ther. 2011 Oct;24(5):505-12. Epub 2011 Apr 2. Review.
Airway disease: the use of large animal models for drug discovery.
Van der Velden J, Snibson KJ.
Pulm Pharmacol Ther. 2011 Oct;24(5):525-32. Epub 2011 Feb 26. Review.
Multiscale mathematical models of airway constriction and disease.
Donovan GM.
Pulm Pharmacol Ther. 2011 Oct;24(5):533-9. Epub 2011 Jan 19. Review.
Association between prescribing patterns of anti-asthmatic drugs and clinically uncontrolled asthma: a cross-sectional study.
Davidsen JR, Hallas J, Søndergaard J, Christensen RD, Siersted HC, Hansen MP, Knudsen TB, Lykkegaard J, Andersen M.
Pulm Pharmacol Ther. 2011 Dec;24(6):647-53. doi: 10.1016/j.pupt.2011.09.001. Epub 2011 Sep 17.
Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children.
Stelmach I, Olszowiec-Chlebna M, Jerzynska J, Grzelewski T, Stelmach W, Majak P.
Pulm Pharmacol Ther. 2011 Aug;24(4):414-20. Epub 2011 Jan 18.
Structural changes in the airways: cause or effect of chronic cough?
Niimi A.
Pulm Pharmacol Ther. 2011 Jun;24(3):328-33. Epub 2011 Feb 1. Review.
The epidemiology of cough.
Kauffmann F, Varraso R.
Pulm Pharmacol Ther. 2011 Jun;24(3):289-94. Epub 2010 Oct 29.
Association of the variants in AGT gene with modified drug response in Korean aspirin-intolerant asthma patients.
Pasaje CF, Kim JH, Park BL, Cheong HS, Park TJ, Lee JS, Kim Y, Bae JS, Kim JM, Park JS, Park CS, Shin HD.
Pulm Pharmacol Ther. 2011 Oct;24(5):595-601. Epub 2011 May 23.
Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma.
Hozawa S, Terada M, Hozawa M.
Pulm Pharmacol Ther. 2011 Oct;24(5):571-6. Epub 2011 May 23.
Two cases of Schizophyllum asthma: is this a new clinical entity or a precursor of ABPM?
Ogawa H, Fujimura M, Takeuchi Y, Makimura K.
Pulm Pharmacol Ther. 2011 Oct;24(5):559-62. Epub 2011 Apr 30.
Conjugated linoleic acid (CLA): is it time to supplement asthma therapy?
Macredmond R, Dorscheid DR.
Pulm Pharmacol Ther. 2011 Oct;24(5):540-8. Epub 2011 Apr 21. Review.
TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
Duechs MJ, Hahn C, Benediktus E, Werner-Klein M, Braun A, Hoymann HG, Gantner F, Erb KJ.
Pulm Pharmacol Ther. 2011 Apr;24(2):203-14. Epub 2010 Dec 31.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on